Structure of ML216
CAS No.: 1430213-30-1
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
ML216 is a potent inhibitor of the DNA unwinding activity of BLM helicase, showing similar IC50s of 3.0 and 0.97 μM for full length BLM and BLM636–1298 respectively.
Synonyms: CID-49852229
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 1430213-30-1 |
Formula : | C15H9F4N5OS |
M.W : | 383.32 |
SMILES Code : | O=C(NC1=CC=C(F)C(C(F)(F)F)=C1)NC2=NN=C(S2)C3=CC=NC=C3 |
Synonyms : |
CID-49852229
|
MDL No. : | MFCD24849400 |
InChI Key : | WMCOYUSJXXCHFH-UHFFFAOYSA-N |
Pubchem ID : | 49852229 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H302-H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Description |
ML216 (CID-49852229) acts as a powerful, selective, and cell-penetrable blocker of BLM helicase's DNA unwinding function, exhibiting IC50 values of 2.98 μM for BLM full-length and 0.97 μM for BLM636-1298. Additionally, ML216 suppresses BLM's ssDNA-dependent ATPase activity with a Ki of 1.76 µM, displaying antitumor activity[1][2].
|
Target |
|
In Vitro:
Cell Line
|
Concentration | Treated Time | Description | References |
XG2 cell line | 4.9 µM | 48 and 96 hours | ML216 induced cell cycle arrest and apoptosis | Front Immunol. 2022 Dec 9;13:983181 |
XG19 cell line | 1.2 µM | 48 and 96 hours | ML216 induced cell cycle arrest and apoptosis | Front Immunol. 2022 Dec 9;13:983181 |
S18 ES cells (BL6 × SPRET F1 hybrid) | 25 μM | 5, 10, or 21 days | induced recombination for genetic mapping, identified Hprt as the gene underlying 6-TG susceptibility | Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3680-3685 |
BL6 × CAST F1 hybrid ES cells | 25 μM | induced mitotic recombination to generate homozygous genotypes | Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3680-3685 | |
mouse embryonic stem (ES) cells | 25 μM | 1 or 5 days | inhibited BLM DNA helicase, induced random mitotic cross-overs, elevated homologous recombination rates | Proc Natl Acad Sci U S A. 2018 Apr 3;115(14):3680-3685 |
CH3+5 HCT116 cells | 8 μM | 72 hours | To evaluate the effect of ML216 on MMR-corrected HCT116 cells, results showed that ML216 had a weaker inhibitory effect on the growth of CH3+5 HCT116 cells. | Proc Natl Acad Sci U S A. 2022 Dec 20;119(51):e2211775119 |
HCT116 cells | 8 μM | 72 hours | To evaluate the inhibitory effect of ML216 on MSI CRC cells, results showed that ML216 significantly inhibited the growth of HCT116 cells and induced PUMA expression and apoptosis. | Proc Natl Acad Sci U S A. 2022 Dec 20;119(51):e2211775119 |
human myeloma cell lines (HMCLs) | 0.78 µM to 100 µM | 4 days | Evaluation of the inhibitory effect of ML216 on HMCLs proliferation, with a median IC50 of 2.78 µM | Front Immunol. 2022 Dec 9;13:983181 |
PC3 cells | 5 μM | 48 hours | To evaluate the inhibitory effects of ML216 combined with olaparib on the proliferation, clonogenicity, invasion, and migration of PC3 cells. Results showed that the combination treatment had stronger inhibitory effects compared to monotherapy. | J Transl Med. 2023 Jul 6;21(1):445 |
A549 cells | 2 µM | 3 or 5 days | To evaluate the proliferation inhibition and radiosensitization effects of ML216 on A549 cells. Results showed ML216 combined with olaparib significantly enhanced the radiosensitivity of A549 cells. | Cancer Biol Med. 2021 Dec 1;19(8):1150–71 |
H1299 cells | 2-10 µM | 3 or 5 days | To evaluate the proliferation inhibition and radiosensitization effects of ML216 on H1299 cells. Results showed ML216 significantly enhanced the radiosensitivity of H1299 cells. | Cancer Biol Med. 2021 Dec 1;19(8):1150–71 |
H460 cells | 2-10 µM | 3 or 5 days | To evaluate the proliferation inhibition and radiosensitization effects of ML216 on H460 cells. Results showed ML216 significantly enhanced the radiosensitivity of H460 cells. | Cancer Biol Med. 2021 Dec 1;19(8):1150–71 |
IMR-90 cells | 50 μM | 24 hours | To evaluate the effect of ML216 on DNA damage-induced senescence, results showed that ML216 significantly reduced the number of senescent cells. | Cells. 2022 Dec 29;12(1):145 |
293T cells | 0, 20, 50, or 100 μM | 12 hours | To evaluate the effect of ML216 on DBC1-BLM interaction, results showed that ML216 concentration-dependently increased the binding of BLM to DBC1. | Cells. 2022 Dec 29;12(1):145 |
WPMY-1 cells | 10 μM | 48 hours | Evaluate the inhibitory effect of ML216 and CDDP on WPMY-1 cell proliferation, showing no synergistic effect in combination therapy | Molecules. 2022 Dec 12;27(24):8790 |
LNCap cells | 10 μM | 48 hours | Evaluate the inhibitory effect of ML216 and CDDP on LNCap cell proliferation, showing that combination therapy has a stronger inhibitory ability | Molecules. 2022 Dec 12;27(24):8790 |
22RV1 cells | 10 μM | 48 hours | Evaluate the inhibitory effect of ML216 and CDDP on 22RV1 cell proliferation, showing that combination therapy has a stronger inhibitory ability | Molecules. 2022 Dec 12;27(24):8790 |
PC3 cells | 10 μM | 48 hours | Evaluate the inhibitory effect of ML216 and CDDP on PC3 cell proliferation, showing that combination therapy has a stronger inhibitory ability | Molecules. 2022 Dec 12;27(24):8790 |
Plasmodium falciparum Dd2 | 1 nM to 1,000 μM | 48 hours | To evaluate the inhibitory effect of ML216 on parasite growth | mSphere. 2020 Nov 25;5(6):e00956-20 |
XG1 cell line | 13.2 µM | 48 and 96 hours | ML216 induced cell cycle arrest and apoptosis | Front Immunol. 2022 Dec 9;13:983181 |
In Vivo:
Species
|
Animal Model
|
Administration | Dosage | Frequency | Description | References |
Nude mice | HCT116 xenograft tumors | Intraperitoneal injection | 1.5 mg/kg | Daily for the first 7 days and then every other day for 13 days | To evaluate the therapeutic effect of ML216 on MSI CRC xenograft tumors, results showed that ML216 significantly suppressed the growth of HCT116 tumors and increased TUNEL and active caspase 3 staining. | Proc Natl Acad Sci U S A. 2022 Dec 20;119(51):e2211775119 |
BALB/c nude mice | PC3 xenograft model | Intraperitoneal injection | 15 mg/kg/d | Three times a week for 3 weeks | To evaluate the inhibitory effects of ML216 combined with olaparib on the growth of PC3 xenograft tumors. Results showed that the combination treatment significantly reduced tumor volume and weight, with no observed toxicity in normal tissues. | J Transl Med. 2023 Jul 6;21(1):445 |
BABL/c Nu/Nu male nude mice | A549 xenograft model | Subcutaneous injection | 25 mg/kg/d | 3 continuous days | To evaluate the radiosensitization effects of ML216 combined with olaparib on A549 xenograft model. Results showed the combination significantly inhibited tumor growth and enhanced radiosensitivity. | Cancer Biol Med. 2021 Dec 1;19(8):1150–71 |
C57BL/6J mice | Naturally aged mouse model and bleomycin-induced idiopathic pulmonary fibrosis (IPF) mouse model | Intraperitoneal injection | 1 mg/kg (naturally aged model) and 0.5 mg/kg (IPF model) | Twice a week for 5 weeks (naturally aged model) or 3 weeks (IPF model) | To evaluate the effect of ML216 on senescence and fibrosis in vivo, results showed that ML216 significantly reduced the number of senescent cells, improved pulmonary function, and decreased the expression of fibrosis markers. | Cells. 2022 Dec 29;12(1):145 |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.61mL 0.52mL 0.26mL |
13.04mL 2.61mL 1.30mL |
26.09mL 5.22mL 2.61mL |
Tags: ML216 | CID-49852229 | ML 216 | ML-216 | CID49852229 | CID 49852229 | DNA/RNA Synthesis | Anticancer | BLM | DNA | unwinding | helicase | toxicity | anti-proliferative | sister chromatid | WRN | inhibitor | 1430213-30-1 |
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :
Total Compounds: mg
The concentration of the dissolution solution you need to prepare is mg/mL